| 15:51 | AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval |  |
| 15:38 | AstraZeneca's Asthma Treatment Tezspire Wins US FDA Approval for Self Administration | |
| 15:10 | TEZSPIRE® approved for self-administration in the US with a new pre-filled pen | |
| 06:05 | WOCHENVORSCHAU: Termine bis 15. Februar 2023 |  |
| 00:32 | U.S. FDA approves GSK's anemia drug for patients on dialysis | |
| 01/02 | Analysis-GSK gives few clues on plans to replenish medicine cabinet | |
| 01/02 | FTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting | |
| 01/02 | Astrazeneca : Transparency Directive - Form 6-K | |
| 01/02 | Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading | |
| 01/02 | GSK: bénéfice 2022 dopé par la scission des soins grand public |  |
| 01/02 | Bolsa de Madrid: No es broma, ¿verdad? |  |
| 01/02 | Pas de blague, hein ? | |
| 01/02 | Novartis says operating profit to grow again ahead of Sandoz spin-off | |
| 31/01 | Borse Europa in calo in vista riunione Bce, balza Unicredit |  |
| 31/01 | European shares drop as focus shifts to cenbank meetings | |
| 31/01 | Las bolsas europeas caen con la atención en las reuniones de los bancos centrales | |
| 31/01 | Marketmind: Mind the gap | |
| 31/01 | WOCHENVORSCHAU: Termine bis 13. Februar 2023 | |
| 30/01 | Drugmakers prevail in dispute over U.S. discount drug program | |
| 30/01 | AstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun.. | |
| 30/01 | Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment | |
| 30/01 | AstraZeneca Enters Research Collaboration with Swedish Medtech Company Capitainer | |
| 30/01 | South Africa Signs Collaboration With Pharmaceutical Association Including GSK, AstraZe.. | |
| 29/01 | 'WamS': Bislang über 250 Corona-Impfschaden-Anträge genehmigt | |
| 27/01 | WOCHENVORSCHAU: Termine bis 10. Februar 2023 | |
| 27/01 | WOCHENVORSCHAU/6. bis 12. Februar (6. KW) | |
| 27/01 | AstraZeneca : retrait de l'autorisation sur Evusheld aux USA | |
| 27/01 | L'appétit grandit | |
| 27/01 | Les valeurs à suivre à Paris et en Europe (actualisé) | |
| 27/01 | US FDA Cancels Emergency Use Nod For AstraZeneca's COVID-19 Drug | |
| 26/01 | ADRs End Higher; AstraZeneca, Diageo Trade Actively | |
| 26/01 | AstraZeneca loses emergency use authorisation for Evusheld | |
| 26/01 | U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld | |
| 26/01 | AstraZeneca's COVID-19 Therapy Evusheld Is No Longer Authorized for Emergency Use by US.. | |
| 26/01 | FDA Halts Authorization of AstraZeneca's Evusheld for Prophylactic Use | |
| 26/01 | Astrazeneca plc Announces Update on US Food and Drug Administration Emergency Use Autho.. | |
| 26/01 | Astrazeneca : Update on US Food and Drug Administration Emergency Use Authorisation of Evu.. | |
| 26/01 | U.S. FDA withdraws authorization for AstraZeneca's Evusheld | |
| 26/01 | Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-lo.. | |
| 26/01 | Sector Update: Health Care Stocks Advance Pre-Bell Thursday | |
| 26/01 | GDP, Trade Data in Focus as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Thursda.. | |
| 26/01 | AstraZeneca, Daiichi Sankyo Say Enhertu Obtains European Approval for Treatment of HER2.. | |
| 26/01 | AstraZeneca : l'UE approuve Enhertu pour le cancer du sein | |
| 26/01 | AstraZeneca's Enhertu approved in EU for breast cancer form | |
| 26/01 | AstraZeneca, Daiichi Sankyo's Enhertu Wins EU Nod for Breast Cancer | |
| 26/01 | Daiichi Sankyo and AstraZeneca’s ENHERTU® Receives Approval in the EU as the First.. | |
| 25/01 | Goldman likes UK banks; HSBC cuts Dr Martens | |
| 24/01 | ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively | |
| 24/01 | FTSE 100 Closes Down 0.35% Amid Mixed PMI Data | |
| 24/01 | Pharma Stocks Weigh Down European Equities in Tuesday Trading | |
| 24/01 | Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Ba.. | |
| 24/01 | Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Deve.. | |
| 24/01 | FTSE 100 dips after weak economic data fans recession fears | |
| 24/01 | FTSE 100 lags as other indices make headway | |
| 24/01 | FTSE 100 lags as other indices make headway | |
| 24/01 | UK's FTSE 100 slips ahead of business activity data | |
| 24/01 | AstraZeneca Initiates Tender Offer For $2 Billion CinCor Takeover | |
| 23/01 | ADRs End Higher; AstraZeneca, Barclays Trade Actively | |
| 23/01 | Biotech IPO Window to Reopen in 2023 Following Muted Activity in 2022, Oppenheimer Says | |
| 23/01 | European Equities Rise as Consumer Confidence Grows | |
| 23/01 | AstraZeneca : ouverture de l'offre amicale sur CinCor | |
| 23/01 | Mehr digitaler Austausch im Kampf gegen Krebs in der EU | |
| 23/01 | AstraZeneca Unit Starts Tender Offer to Purchase CinCor Pharma | |
| 23/01 | AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc. | |
| 23/01 | Jefferies cuts Berkeley; HSBC cuts St James's | |
| 20/01 | FTSE 100 Closes Up 0.3% After Strong Start to Year | |
| 20/01 | FTSE 100 steadies after difficult week | |
| 20/01 | AstraZeneca : titre en retrait, un broker livre son conseil | |
| 20/01 | AstraZeneca Might Potentially Lose Billions in 2023 | |
| 20/01 | AstraZeneca : Stifel abaisse sa cible, prudent pour 2023 | |
| 20/01 | Bank of America raises Asos, boohoo to 'buy' | |
| 19/01 | Goldman Sachs cuts Relx but raises WPP | |
| 19/01 | Hutchmed's Lung Cancer Treatment Added to China's National Reimbursement Drug List | |
| 18/01 | Factbox-Moderna data puts the spotlight on RSV vaccines under development | |
| 18/01 | HUTCHMED Announces Inclusion of Orpathys in National Reimbursement Drug List in China | |
| 18/01 | Reunion Neuroscience Appoints Former Takeda, Pfizer Executive as Chief Medical Officer | |
| 18/01 | Hutchmed-AstraZeneca Cancer Drug Included in China’s Reimbursement Drug List | |
| 18/01 | How long will this bullish phase last? | |
| 18/01 | Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Ora.. | |
| 18/01 | AstraZeneca : Berenberg rehausse son objectif de cours | |
| 18/01 | Bank of America and Oddo BHF cut Whitbread | |
| 18/01 | Bolsa de Madrid: ¡Ya no baja! | |
| 18/01 | Ça baisse plus ! | |
| 18/01 | Avis d'analystes du jour : L'Oréal, Capgemini, Technip Energies.. | |
| 18/01 | UPS AND DOWNS "The FTSE ... | |
| 18/01 | Moderna data puts the spotlight on RSV vaccines under development | |
| 17/01 | FTSE 100 Closes Down 0.1% Amid AstraZeneca, Unilever Weakness | |
| 17/01 | FTSE 100 Closes Down 0.1% Amid AstraZeneca, -2- | |
| 17/01 | FTSE 100 Closes Down 0.1% Amid AstraZeneca, -3- | |
| 17/01 | Astrazeneca - Acquisition of Neogene Therapeutics completed | |
| 17/01 | AIM ImmunoTech, AstraZeneca Enter Collaborative Study for Pancreatic Cancer Treatment; .. | |
| 17/01 | AIM ImmunoTech Signs Pancreatic Cancer Clinical Research Deals With AstraZeneca, Erasmu.. | |
| 17/01 | AIM ImmunoTech Inc. Enters into Pancreatic Cancer Clinical Research Agreements with Ast.. | |
| 17/01 | FTSE 100 snaps four-day winning streak as Britain's Ocado slumps | |
| 16/01 | Innate Pharma bondit grâce à sa coopération avec Sanofi sur les cellules NK | |
| 16/01 | JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO | |
| 16/01 | Acquisition of Neogene Therapeutics completed | |
| 16/01 | AstraZeneca completes acquisition of Neogene Therapeutics | |
| 16/01 | AstraZeneca : finalisation de l'acquisition de Neogene | |
| 16/01 | FTSE 100 seen flat; Just Eat and Sainsbury's partner | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
